Long-term efficacy, safety, and inhibition of joint destruction by adalimumab in psoriatic arthritis: Results from ADEPT

被引：0
|
作者：
Mease, Philip J.
Gladman, Dafna
Ritchlin, Christopher
Sasso, Eric
机构：
[1] Swedish Med Ctr, Seattle, WA USA
[2] Univ Toronto, Toronto, ON, Canada
[3] Univ Rochester, Sch Med & Dent, Rochester, NY 14627 USA
[4] Abbott Labs, Abbott Pk, IL 60064 USA
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2007年 / 127卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
104
引用
收藏
页码：1820 / 1820
页数：1
相关论文
共 50 条
  • [31] Long-term safety and efficacy of low-dose cyclosporin A in severe psoriatic arthritis
    Sarzi-Puttini, P
    Cazzola, M
    Panni, B
    Turiel, M
    Fiorini, T
    Belai-Beyene, N
    Chèrié-Lignièré, EL
    RHEUMATOLOGY INTERNATIONAL, 2002, 21 (06) : 234 - 238
  • [32] Long-term safety and efficacy of low-dose cyclosporin A in severe psoriatic arthritis
    Piercarlo Sarzi-Puttini
    Marco Cazzola
    Benedetta Panni
    Maurizio Turiel
    Tania Fiorini
    Nebiat Belai-Beyene
    Enrico Chèrié-Lignièré
    Rheumatology International, 2002, 21 : 234 - 238
  • [33] Long-term efficacy and safety of infliximab in the treatment of patients affected by psoriasis and psoriatic arthritis
    Papoutsaki, M.
    Talamonti, M.
    Giunta, A.
    Costanzo, A.
    Chimenti, S.
    BRITISH JOURNAL OF DERMATOLOGY, 2008, 159 : 47 - 48
  • [34] Long-term efficacy and safety of adalimumab in children with juvenile rheumatoid arthritis (JRA): 48-week results.
    Lovell, D. J.
    Ruperto, N.
    Jung, L.
    Reiff, A.
    Nemcova, D.
    Jarosova, K.
    Prieur, A.
    Sandborg, C.
    Rovensky, J.
    Bohnsack, J.
    Minden, K.
    Weiner, L. Wagner
    Vehe, R.
    Horneff, G.
    Medich, J.
    Giannini, E. H.
    Martini, A.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S303 - S303
  • [35] Long-term efficacy and safety of switching from adalimumab to risankizumab: results from the open label extension LIMMitless
    Reich, Kristian
    Ryan, Caitriona
    Crowley, Jeffrey
    Szepietowski, Jacek C.
    Zeng, Jiewei
    Valdes, Joaquin
    Photowala, Huzefa
    Kaufmann, Christian
    Gooderham, Melinda
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2020, 18 : 19 - 20
  • [36] Safety of adalimumab in long-term treatment of patients with rheumatoid arthritis
    Schiff, M
    Burmester, GR
    Kent, J
    Pangan, A
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2005, 52 (03) : P203 - P203
  • [37] Long-Term Efficacy and Safety of Adalimumab for up to 6 Years in Patients with Juvenile Idiopathic Arthritis
    Lovell, Daniel J.
    Ruperto, Nicolino
    Reiff, Andreas
    Jung, Lawrence K.
    Higgins, Gloria
    Kone-Paut, Isabelle
    Jones, Olcay Y.
    McIlraith, Melissa J.
    Andhivarothai, Nupun
    Kupper, Hartmut
    Giannini, Edward H.
    Peterson, Theresa
    Martini, Alberto
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S99 - S99
  • [38] Improvement in psoriasis is associated with long-term inhibition of radiographic progression in patients with psoriatic arthritis receiving adalimumab (HUMIRA®)
    Choy, Ernest
    Gladman, Dafna D.
    Mease, Philip
    Ritchlin, Christopher
    Olds, Michele
    Wong, Robert
    Wang, Shuhe
    Medich, John
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S575 - S576
  • [39] THE IMMUNOGENICITY OF BIOLOGICAL THERAPIES CORRELATES WITH CLINICAL EFFICACY IN PSORIATIC ARTHRITIS (PSA) IN LONG-TERM TREATMENT WITH INFLIXIMAB AND ADALIMUMAB
    Cajigas, D.
    Plasencia, C.
    Pascual-Salcedo, D.
    Bonilla, G.
    Alcocer, P.
    Garcia-Carazo, S.
    Franco, K. N.
    Lojo, L.
    Nuno, L.
    Villalba, A.
    Peiteado, D.
    Ramiro, S.
    Lopez-Casla, M. T.
    Diez, J.
    Martin-Mola, E.
    Balsa, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 964 - 965
  • [40] Long-term safety and efficacy of upadacitinib or adalimumab in patients with rheumatoid arthritis: results through 3 years from the SELECT-COMPARE study
    Fleischmann, Roy
    Mysler, Eduardo
    Bessette, Louis
    Peterfy, Charles G.
    Durez, Patrick
    Tanaka, Yoshiya
    Swierkot, Jerzy
    Khan, Nasser
    Bu, Xianwei
    Li, Yihan
    Song, In-Ho
    RMD OPEN, 2022, 8 (01):
12345